Search

everythinglearnresearchcommunity

for

Search:↓

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

A rare form of lupus can cause severe nerve damage and other symptoms, but treatment can help.

Managing lipids may help treat hair loss.

Alopecia areata involves immune response and gene changes affecting hair loss.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Early recognition and management of connective tissue diseases like lupus are crucial in young patients.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

AKN is a chronic scalp condition in African-descended males, treated with topicals, antibiotics, steroids, and sometimes surgery or laser.

Cannabinoids may help treat various skin conditions.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

The monkey's hair loss was due to an autoimmune disease, not genetics.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

KAP genes are crucial for hair development and show both shared and unique traits in humans, chimpanzees, and baboons.

Vitamin D supplements may reduce hair-pulling in people with Trichotillomania.

Hair loss in alopecia areata can negatively affect sexual quality of life.